-
1
-
-
0035100888
-
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
-
Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics. 2001;69:89-95.
-
(2001)
Clinical pharmacology and therapeutics
, vol.69
, pp. 89-95
-
-
-
3
-
-
79961025970
-
MicroRNAs in body fluids-the mix of hormones and biomarkers
-
Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nature reviews Clinical oncology. 2011;8:467-77.
-
(2011)
Nature reviews Clinical oncology
, vol.8
, pp. 467-477
-
-
Cortez, M.A.1
Bueso-Ramos, C.2
Ferdin, J.3
Lopez-Berestein, G.4
Sood, A.K.5
Calin, G.A.6
-
4
-
-
84905995702
-
Cancer Affects microRNA Expression, Release, and Function in Cardiac and Skeletal Muscle
-
Chen D, Goswami CP, Burnett RM, Anjanappa M, Bhat-Nakshatri P, Muller W, et al. Cancer Affects microRNA Expression, Release, and Function in Cardiac and Skeletal Muscle. Cancer research. 2014;74:4270-81.
-
(2014)
Cancer research
, vol.74
, pp. 4270-4281
-
-
Chen, D.1
Goswami, C.P.2
Burnett, R.M.3
Anjanappa, M.4
Bhat-Nakshatri, P.5
Muller, W.6
-
5
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:10513-8.
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
Fritz, B.R.4
Wyman, S.K.5
Pogosova-Agadjanyan, E.L.6
-
6
-
-
84867081983
-
Systemic mirnas as potential biomarkers for malignancy
-
Healy NA, Heneghan HM, Miller N, Osborne CK, Schiff R, Kerin MJ. Systemic mirnas as potential biomarkers for malignancy. International journal of cancer. 2012;131:2215-22.
-
(2012)
International journal of cancer
, vol.131
, pp. 2215-2222
-
-
Healy, N.A.1
Heneghan, H.M.2
Miller, N.3
Osborne, C.K.4
Schiff, R.5
Kerin, M.J.6
-
7
-
-
84863425849
-
Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases
-
Weiland M, Gao XH, Zhou L, Mi QS. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA biology. 2012;9:850-9.
-
(2012)
RNA biology
, vol.9
, pp. 850-859
-
-
Weiland, M.1
Gao, X.H.2
Zhou, L.3
Mi, Q.S.4
-
8
-
-
84875033024
-
Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations
-
Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proceedings of the National Academy of Sciences of the United States of America. 2013;110:4255-60.
-
(2013)
Proceedings of the National Academy of Sciences of the United States of America
, vol.110
, pp. 4255-4260
-
-
Williams, Z.1
Ben-Dov, I.Z.2
Elias, R.3
Mihailovic, A.4
Brown, M.5
Rosenwaks, Z.6
-
9
-
-
84875706825
-
Resistance to BRAF-targeted therapy in melanoma
-
Sullivan RJ, Flaherty KT. Resistance to BRAF-targeted therapy in melanoma. Eur J Cancer. 2013;49:1297-304.
-
(2013)
Eur J Cancer
, vol.49
, pp. 1297-1304
-
-
Sullivan, R.J.1
Flaherty, K.T.2
-
12
-
-
84891095490
-
Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease
-
Achberger S, Aldrich W, Tubbs R, Crabb JW, Singh AD, Triozzi PL. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Molecular immunology. 2014;58:182-6.
-
(2014)
Molecular immunology
, vol.58
, pp. 182-186
-
-
Achberger, S.1
Aldrich, W.2
Tubbs, R.3
Crabb, J.W.4
Singh, A.D.5
Triozzi, P.L.6
-
13
-
-
84864486967
-
Serum microRNAs as biomarkers for recurrence in melanoma
-
Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, et al. Serum microRNAs as biomarkers for recurrence in melanoma. Journal of translational medicine. 2012;10:155.
-
(2012)
Journal of translational medicine
, vol.10
, pp. 155
-
-
Friedman, E.B.1
Shang, S.2
de Miera, E.V.3
Fog, J.U.4
Teilum, M.W.5
Ma, M.W.6
-
14
-
-
77953029993
-
High-throughput miRNA profiling of human melanoma blood samples
-
Leidinger P, Keller A, Borries A, Reichrath J, Rass K, Jager SU, et al. High-throughput miRNA profiling of human melanoma blood samples. BMC cancer. 2010;10:262.
-
(2010)
BMC cancer
, vol.10
, pp. 262
-
-
Leidinger, P.1
Keller, A.2
Borries, A.3
Reichrath, J.4
Rass, K.5
Jager, S.U.6
-
15
-
-
84876684076
-
Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma
-
Saldanha G, Potter L, Shendge P, Osborne J, Nicholson S, Yii N, et al. Plasma microRNA-21 is associated with tumor burden in cutaneous melanoma. The Journal of investigative dermatology. 2013;133:1381-4.
-
(2013)
The Journal of investigative dermatology
, vol.133
, pp. 1381-1384
-
-
Saldanha, G.1
Potter, L.2
Shendge, P.3
Osborne, J.4
Nicholson, S.5
Yii, N.6
-
16
-
-
84885193248
-
A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study
-
Greenberg E, Besser MJ, Ben-Ami E, Shapira-Frommer R, Itzhaki O, Zikich D, et al. A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. Biomarkers. 2013;18:502-8.
-
(2013)
Biomarkers
, vol.18
, pp. 502-508
-
-
Greenberg, E.1
Besser, M.J.2
Ben-Ami, E.3
Shapira-Frommer, R.4
Itzhaki, O.5
Zikich, D.6
-
17
-
-
84918830062
-
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
-
Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 2015; 121:51-9.
-
(2015)
Cancer
, vol.121
, pp. 51-59
-
-
Fleming, N.H.1
Zhong, J.2
da Silva, I.P.3
Vega-Saenz de Miera, E.4
Brady, B.5
Han, S.W.6
-
18
-
-
84907809960
-
The validity of circulating microRNAs in oncology: five years of challenges and contradictions
-
Jarry J, Schadendorf D, Greenwood C, Spatz A, van Kempen LC. The validity of circulating microRNAs in oncology: five years of challenges and contradictions. Molecular oncology. 2014;8:819-29.
-
(2014)
Molecular oncology
, vol.8
, pp. 819-829
-
-
Jarry, J.1
Schadendorf, D.2
Greenwood, C.3
Spatz, A.4
van Kempen, L.C.5
-
19
-
-
84884471107
-
Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers
-
Koberle V, Pleli T, Schmithals C, Augusto Alonso E, Haupenthal J, Bonig H, et al. Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers. PloS one. 2013;8:e75184.
-
(2013)
PloS one
, vol.8
-
-
Koberle, V.1
Pleli, T.2
Schmithals, C.3
Augusto Alonso, E.4
Haupenthal, J.5
Bonig, H.6
-
20
-
-
79957784825
-
Analysis of circulating microRNA: preanalytical and analytical challenges
-
McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clinical chemistry. 2011;57:833-40.
-
(2011)
Clinical chemistry
, vol.57
, pp. 833-840
-
-
McDonald, J.S.1
Milosevic, D.2
Reddi, H.V.3
Grebe, S.K.4
Algeciras-Schimnich, A.5
-
22
-
-
84859464569
-
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies
-
Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492-7.
-
(2012)
Cancer Prev Res (Phila)
, vol.5
, pp. 492-497
-
-
Pritchard, C.C.1
Kroh, E.2
Wood, B.3
Arroyo, J.D.4
Dougherty, K.J.5
Miyaji, M.M.6
-
23
-
-
84867278201
-
Analytical challenges and technical limitations in assessing circulating miRNAs
-
Zampetaki A, Mayr M. Analytical challenges and technical limitations in assessing circulating miRNAs. Thrombosis and haemostasis. 2012;108:592-8.
-
(2012)
Thrombosis and haemostasis
, vol.108
, pp. 592-598
-
-
Zampetaki, A.1
Mayr, M.2
-
24
-
-
84857930607
-
Profiling of circulating microRNAs: from single biomarkers to re-wired networks
-
Zampetaki A, Willeit P, Drozdov I, Kiechl S, Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovascular research. 2012;93:555-62.
-
(2012)
Cardiovascular research
, vol.93
, pp. 555-562
-
-
Zampetaki, A.1
Willeit, P.2
Drozdov, I.3
Kiechl, S.4
Mayr, M.5
-
25
-
-
77649205818
-
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
-
Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298-301.
-
(2010)
Methods
, vol.50
, pp. 298-301
-
-
Kroh, E.M.1
Parkin, R.K.2
Mitchell, P.S.3
Tewari, M.4
-
26
-
-
84905241949
-
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study
-
Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nature methods. 2014;11:809-15.
-
(2014)
Nature methods
, vol.11
, pp. 809-815
-
-
Mestdagh, P.1
Hartmann, N.2
Baeriswyl, L.3
Andreasen, D.4
Bernard, N.5
Chen, C.6
-
27
-
-
84876386633
-
Assessing sample and miRNA profile quality in serum and plasma or other biofluids
-
Blondal T, Jensby Nielsen S, Baker A, Andreasen D, Mouritzen P, Wrang Teilum M, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1-6.
-
(2013)
Methods
, vol.59
, pp. S1-S6
-
-
Blondal, T.1
Jensby Nielsen, S.2
Baker, A.3
Andreasen, D.4
Mouritzen, P.5
Wrang Teilum, M.6
-
29
-
-
80053367552
-
Toward the blood-borne miRNome of human diseases
-
Keller A, Leidinger P, Bauer A, Elsharawy A, Haas J, Backes C, et al. Toward the blood-borne miRNome of human diseases. Nature methods. 2011;8:841-3.
-
(2011)
Nature methods
, vol.8
, pp. 841-843
-
-
Keller, A.1
Leidinger, P.2
Bauer, A.3
Elsharawy, A.4
Haas, J.5
Backes, C.6
-
30
-
-
84883783640
-
Micro-managing the circadian clock: The role of microRNAs in biological timekeeping
-
Mehta N, Cheng HY. Micro-managing the circadian clock: The role of microRNAs in biological timekeeping. Journal of molecular biology. 2013;425:3609-24.
-
(2013)
Journal of molecular biology
, vol.425
, pp. 3609-3624
-
-
Mehta, N.1
Cheng, H.Y.2
-
31
-
-
84906223134
-
MicroRNAs function as cis-and trans-acting modulators of peripheral circadian clocks
-
Shende VR, Kim SM, Neuendorff N, Earnest DJ. MicroRNAs function as cis-and trans-acting modulators of peripheral circadian clocks. FEBS letters. 2014;588:3015-22.
-
(2014)
FEBS letters
, vol.588
, pp. 3015-3022
-
-
Shende, V.R.1
Kim, S.M.2
Neuendorff, N.3
Earnest, D.J.4
-
32
-
-
84922710918
-
Circulating microRNAs in aging
-
Bonafe M, Olivieri F. Circulating microRNAs in aging. Oncotarget. 2015;6:1340-1.
-
(2015)
Oncotarget
, vol.6
, pp. 1340-1341
-
-
Bonafe, M.1
Olivieri, F.2
-
33
-
-
84867327663
-
Identifying mRNA, microRNA and protein profiles of melanoma exosomes
-
Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, Waigel S, et al. Identifying mRNA, microRNA and protein profiles of melanoma exosomes. PloS one. 2012;7:e46874.
-
(2012)
PloS one
, vol.7
-
-
Xiao, D.1
Ohlendorf, J.2
Chen, Y.3
Taylor, D.D.4
Rai, S.N.5
Waigel, S.6
-
34
-
-
84883532245
-
New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion
-
Margue C, Philippidou D, Reinsbach SE, Schmitt M, Behrmann I, Kreis S. New target genes of MITF-induced microRNA-211 contribute to melanoma cell invasion. PloS one. 2013;8:e73473.
-
(2013)
PloS one
, vol.8
-
-
Margue, C.1
Philippidou, D.2
Reinsbach, S.E.3
Schmitt, M.4
Behrmann, I.5
Kreis, S.6
-
35
-
-
79956054502
-
Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor
-
Boyle GM, Woods SL, Bonazzi VF, Stark MS, Hacker E, Aoude LG, et al. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment cell & melanoma research. 2011;24:525-37.
-
(2011)
Pigment cell & melanoma research
, vol.24
, pp. 525-537
-
-
Boyle, G.M.1
Woods, S.L.2
Bonazzi, V.F.3
Stark, M.S.4
Hacker, E.5
Aoude, L.G.6
-
36
-
-
78649903941
-
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma
-
Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S, et al. Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Molecular cell. 2010;40:841-9.
-
(2010)
Molecular cell
, vol.40
, pp. 841-849
-
-
Levy, C.1
Khaled, M.2
Iliopoulos, D.3
Janas, M.M.4
Schubert, S.5
Pinner, S.6
-
37
-
-
78249288790
-
The regulation of miRNA-211 expression and its role in melanoma cell invasiveness
-
Mazar J, DeYoung K, Khaitan D, Meister E, Almodovar A, Goydos J, et al. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness. PloS one. 2010;5:e13779.
-
(2010)
PloS one
, vol.5
-
-
Mazar, J.1
DeYoung, K.2
Khaitan, D.3
Meister, E.4
Almodovar, A.5
Goydos, J.6
-
38
-
-
34047270440
-
Characterization of microRNA expression levels and their biological correlates in human cancer cell lines
-
Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer research. 2007;67:2456-68.
-
(2007)
Cancer research
, vol.67
, pp. 2456-2468
-
-
Gaur, A.1
Jewell, D.A.2
Liang, Y.3
Ridzon, D.4
Moore, J.H.5
Chen, C.6
-
39
-
-
79955759815
-
Global microRNA analysis of the NCI-60 cancer cell panel
-
Sokilde R, Kaczkowski B, Podolska A, Cirera S, Gorodkin J, Moller S, et al. Global microRNA analysis of the NCI-60 cancer cell panel. Molecular cancer therapeutics. 2011;10:375-84.
-
(2011)
Molecular cancer therapeutics
, vol.10
, pp. 375-384
-
-
Sokilde, R.1
Kaczkowski, B.2
Podolska, A.3
Cirera, S.4
Gorodkin, J.5
Moller, S.6
-
40
-
-
77952838399
-
Signatures of microRNAs and selected microRNA target genes in human melanoma
-
Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, et al. Signatures of microRNAs and selected microRNA target genes in human melanoma. Cancer research. 2010;70:4163-73.
-
(2010)
Cancer research
, vol.70
, pp. 4163-4173
-
-
Philippidou, D.1
Schmitt, M.2
Moser, D.3
Margue, C.4
Nazarov, P.V.5
Muller, A.6
-
42
-
-
84891790713
-
Current status of diagnostic and prognostic markers in melanoma
-
Levine D, Fisher DE. Current status of diagnostic and prognostic markers in melanoma. Methods Mol Biol. 2014;1102:177-97.
-
(2014)
Methods Mol Biol
, vol.1102
, pp. 177-197
-
-
Levine, D.1
Fisher, D.E.2
-
43
-
-
84907323440
-
Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
-
Enroth S, Johansson A, Enroth SB, Gyllensten U. Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs. Nature communications. 2014;5:4684.
-
(2014)
Nature communications
, vol.5
, pp. 4684
-
-
Enroth, S.1
Johansson, A.2
Enroth, S.B.3
Gyllensten, U.4
-
44
-
-
84863012463
-
Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
-
Xu Y, Brenn T, Brown ER, Doherty V, Melton DW. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. British journal of cancer. 2012;106:553-61.
-
(2012)
British journal of cancer
, vol.106
, pp. 553-561
-
-
Xu, Y.1
Brenn, T.2
Brown, E.R.3
Doherty, V.4
Melton, D.W.5
-
45
-
-
84876717265
-
MiRNA-29: a microRNA family with tumor-suppressing and immunemodulating properties
-
Schmitt MJ, Margue C, Behrmann I, Kreis S. MiRNA-29: a microRNA family with tumor-suppressing and immunemodulating properties. Current molecular medicine. 2013;13:572-85.
-
(2013)
Current molecular medicine
, vol.13
, pp. 572-585
-
-
Schmitt, M.J.1
Margue, C.2
Behrmann, I.3
Kreis, S.4
-
46
-
-
84872107869
-
Interferongamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells
-
Schmitt MJ, Philippidou D, Reinsbach SE, Margue C, Wienecke-Baldacchino A, Nashan D, et al. Interferongamma-induced activation of Signal Transducer and Activator of Transcription 1 (STAT1) up-regulates the tumor suppressing microRNA-29 family in melanoma cells. Cell communication and signaling: 2012;10:41.
-
(2012)
Cell communication and signaling :
, vol.10
, pp. 41
-
-
Schmitt, M.J.1
Philippidou, D.2
Reinsbach, S.E.3
Margue, C.4
Wienecke-Baldacchino, A.5
Nashan, D.6
-
47
-
-
84883420810
-
In-depth characterization of microRNA transcriptome in melanoma
-
Kozubek J, Ma Z, Fleming E, Duggan T, Wu R, Shin DG, et al. In-depth characterization of microRNA transcriptome in melanoma. PloS one. 2013;8:e72699.
-
(2013)
PloS one
, vol.8
-
-
Kozubek, J.1
Ma, Z.2
Fleming, E.3
Duggan, T.4
Wu, R.5
Shin, D.G.6
-
50
-
-
84866093563
-
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway
-
Zhuang G, Wu X, Jiang Z, Kasman I, Yao J, Guan Y, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. The EMBO journal. 2012;31:3513-23.
-
(2012)
The EMBO journal
, vol.31
, pp. 3513-3523
-
-
Zhuang, G.1
Wu, X.2
Jiang, Z.3
Kasman, I.4
Yao, J.5
Guan, Y.6
-
52
-
-
34249302620
-
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
-
Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature cell biology. 2007;9:654-9.
-
(2007)
Nature cell biology
, vol.9
, pp. 654-659
-
-
Valadi, H.1
Ekstrom, K.2
Bossios, A.3
Sjostrand, M.4
Lee, J.J.5
Lotvall, J.O.6
-
54
-
-
84924844479
-
Isolation of circulating microRNA associated with RNA-binding protein
-
Turchinovich A, Weiz L, Burwinkel B. Isolation of circulating microRNA associated with RNA-binding protein. Methods Mol Biol. 2013;1024:97-107.
-
(2013)
Methods Mol Biol
, vol.1024
, pp. 97-107
-
-
Turchinovich, A.1
Weiz, L.2
Burwinkel, B.3
-
55
-
-
80052360838
-
Haemolysis during sample preparation alters microRNA content of plasma
-
Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, van Zandwijk N, et al. Haemolysis during sample preparation alters microRNA content of plasma. PloS one. 2011;6:e24145.
-
(2011)
PloS one
, vol.6
-
-
Kirschner, M.B.1
Kao, S.C.2
Edelman, J.J.3
Armstrong, N.J.4
Vallely, M.P.5
van Zandwijk, N.6
-
57
-
-
79952709519
-
pROC: an open-source package for R and S+ to analyze and compare ROC curves
-
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics. 2011;12:77.
-
(2011)
BMC bioinformatics
, vol.12
, pp. 77
-
-
Robin, X.1
Turck, N.2
Hainard, A.3
Tiberti, N.4
Lisacek, F.5
Sanchez, J.C.6
-
58
-
-
80053178761
-
An intuitive graphical visualization technique for the interrogation of transcriptome data
-
Bushati N, Smith J, Briscoe J, Watkins C. An intuitive graphical visualization technique for the interrogation of transcriptome data. Nucleic acids research. 2011;39:7380-9.
-
(2011)
Nucleic acids research
, vol.39
, pp. 7380-7389
-
-
Bushati, N.1
Smith, J.2
Briscoe, J.3
Watkins, C.4
|